STAT3 and atherosclerosis: Mechanistically, this is probably a consequence of IL10 overexpression, which has been associated with protection against atherosclerosis in the LDLR(−/−) model and is a hallmark characteristic of the LysMPTP1B(−/−) genotype through a disruption in the negative IL10-STAT3 feedback-loop [15].